| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Institut für Biochemische Pharmakologie (S.S., S.H.), Innsbruck, Austria; and A.V. Vishnevsky Institute of Surgery (E.T.), Moscow, Russia.
Correspondence to Steffen Hering, Institut für Biochemische Pharmakologie, Peter-Mayr-Straße 1, A-6020 Innsbruck, Austria. E-mail Steffen.Hering.{at}uibk.ac.at
Abstract L-type calcium channels (Cav1.m) inactivate in response to elevation of intracellular Ca2+ (Ca2+-dependent inactivation) and additionally by conformational changes induced by membrane depolarization (fast and slow voltage-dependent inactivation). Molecular determinants of inactivation play an essential role in channel inhibition by phenylalkylamines (PAAs). The relative impacts, however, of Ca2+-dependent and voltage-dependent inactivation in Cav1.2 sensitivity for PAAs remain unknown. In order to analyze the role of the different inactivation processes, we expressed Cav1.2 constructs composed of different ß-subunits (ß1a-, ß2a-, or ß3-subunit) in Xenopus oocytes and estimated their (-)gallopamil sensitivity by means of the two-microelectrode voltage clamp with either Ba2+ or Ca2+ as charge carrier. Cav1.2 consisting of the ß2a-subunit displayed the slowest inactivation and the lowest apparent sensitivity for the PAA (-)gallopamil. A significantly higher apparent (-)gallopamil-sensitivity with Ca2+ as charge carrier was observed for all 3 ß-subunit compositions. The kinetics of Ca2+-dependent inactivation and slow voltage-dependent inactivation were not affected by drug. The higher sensitivity of the Cav1.2 channels for (-)gallopamil with Ca2+ as charge carrier results from slower recovery (
rec,Ca
15 seconds versus
rec,Ba
3 to 5 seconds) from a PAA-induced channel conformation. We propose a model where (-)gallopamil promotes a fast voltage-dependent component in Cav1.2 inactivation. The model reproduces the higher drug sensitivity in Ca2+ as well as the lower sensitivity of slowly inactivating Cav1.2 composed of the ß2a-subunit.
Key Words: Cav1.2 ß-subunit Ca2+-dependent inactivation voltage-dependent inactivation PAA (-)gallopamil
This article has been cited by other articles:
![]() |
R. C. K. Cheng, D. B. Tikhonov, and B. S. Zhorov Structural Model for Phenylalkylamine Binding to L-type Calcium Channels J. Biol. Chem., October 9, 2009; 284(41): 28332 - 28342. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dilmac, N. Hilliard, and G. H. Hockerman Molecular Determinants of Frequency Dependence and Ca2+ Potentiation of Verapamil Block in the Pore Region of Cav1.2 Mol. Pharmacol., November 1, 2004; 66(5): 1236 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dilmac, N. Hilliard, and G. H. Hockerman Molecular Determinants of Ca2+ Potentiation of Diltiazem Block and Ca2+-Dependent Inactivation in the Pore Region of Cav1.2 Mol. Pharmacol., August 1, 2003; 64(2): 491 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bodi, S. E. Koch, H. Yamaguchi, G. P. Szigeti, A. Schwartz, and G. Varadi The Role of Region IVS5 of the Human Cardiac Calcium Channel in Establishing Inactivated Channel Conformation. USE-DEPENDENT BLOCK BY BENZOTHIAZEPINES J. Biol. Chem., May 31, 2002; 277(23): 20651 - 20659. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |